New drug duo tested in battle against tough head and neck cancers
NCT ID NCT07254585
Summary
This study is testing whether a new combination of two drugs, SYS6010 and enlonstobart, can help control advanced head and neck cancer that has returned or spread. It will involve about 70 adults whose cancer is not suitable for surgery or standard radiation/chemotherapy. The main goals are to see if the treatment shrinks tumors and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai East Hospital Affiliated To Tongji University
RECRUITINGShanghai, Shanghai Municipality, 100176, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.